BioNTech (BNTX) News Today → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free BNTX Stock Alerts $92.21 +2.08 (+2.31%) (As of 10:28 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBioNTech (NASDAQ:BNTX) PT Raised to $98.00americanbankingnews.com - May 9 at 4:08 AMDeutsche Numis Reaffirms Their Hold Rating on BioNTech SE (BNTX)markets.businessinsider.com - May 8 at 2:10 PMBioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Yearfinance.yahoo.com - May 8 at 2:10 PMBioNTech (NASDAQ:BNTX) Price Target Raised to $113.00marketbeat.com - May 8 at 8:37 AMBuy Rating Affirmed for BioNTech Amid Strong Financials and Promising Oncology Pipelinemarkets.businessinsider.com - May 8 at 6:39 AMBioNTech (NASDAQ:BNTX) Price Target Lowered to $122.00 at BMO Capital Marketsamericanbankingnews.com - May 8 at 5:30 AMBioNTech (NASDAQ:BNTX) Price Target Raised to $98.00 at TD Cowenamericanbankingnews.com - May 8 at 5:30 AMStrong Financials and Promising Oncology Pipeline Support Buy Rating for BioNTech SEmarkets.businessinsider.com - May 7 at 8:38 PMBioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionmsn.com - May 7 at 3:37 PMBioNTech (NASDAQ:BNTX) PT Lowered to $122.00marketbeat.com - May 7 at 12:24 PMBuy Rating for BioNTech SE on Strong H2 Revenue Outlook and Promising Oncology Pipelinemarkets.businessinsider.com - May 7 at 10:37 AMBioNTech: Hold Rating Maintained Amidst Lower Q1 Earnings and Steady Revenue Outlookmarkets.businessinsider.com - May 7 at 5:36 AMBioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)americanbankingnews.com - May 7 at 1:32 AMBioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Toplinemsn.com - May 6 at 7:36 PMWhat's Going With BioNTech Stock On Monday?finance.yahoo.com - May 6 at 7:36 PMBioNTech Se (BNTX) Q1 2024 Earnings Call Transcriptfool.com - May 6 at 7:36 PMBioNTech (NASDAQ:BNTX) Shares Gap Down to $92.72marketbeat.com - May 6 at 5:56 PMBNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 6 at 1:32 PMBioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)marketbeat.com - May 6 at 12:51 PMBioNTech SE 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 6 at 12:30 PMBioNTech's Outlook Gives Vaccine Maker a Shot in the Arminvestopedia.com - May 6 at 11:25 AMBioNTech Revenue Falls Sharply on Reduced Covid Vaccine Salesbarrons.com - May 6 at 7:31 AMBioNTech SE: BioNTech Announces First Quarter 2024 Financial Results and Corporate Updatefinanznachrichten.de - May 6 at 7:23 AMBioNTech Swings to Net Loss on Lower Covid Vaccine Salesmarketwatch.com - May 6 at 7:23 AMBioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-marketmarkets.businessinsider.com - May 6 at 7:23 AMBioNTech Slips To Loss In Q1markets.businessinsider.com - May 6 at 7:23 AMBioNTech says 90% of 2024 revenues will accrue at end of yearreuters.com - May 6 at 6:52 AMBioNTech Announces First Quarter 2024 Financial Results and Corporate Updateglobenewswire.com - May 6 at 6:45 AMKestra Private Wealth Services LLC Buys New Position in BioNTech SE (NASDAQ:BNTX)marketbeat.com - May 5 at 6:35 AMBioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Companyseekingalpha.com - May 3 at 9:31 AMBioNTech Earnings Preview: I Will Stay On The Sidelinesseekingalpha.com - May 3 at 9:25 AMVan ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)marketbeat.com - May 3 at 6:20 AMBioNTech (BNTX) to Release Earnings on Mondayamericanbankingnews.com - April 29 at 3:46 AMCOVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battlemsn.com - April 26 at 5:12 PM103,858 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by abrdn plcmarketbeat.com - April 26 at 6:13 AMWhat's Going On With Pfizer Stock On Thursday?msn.com - April 25 at 6:44 PMGSK sues Pfizer, BioNTech over COVID-19 vaccines patentsmsn.com - April 25 at 1:43 PMGlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyreuters.com - April 25 at 9:40 AMMackenzie Financial Corp Has $2.30 Million Stake in BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 23 at 5:11 AMBioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024globenewswire.com - April 22 at 6:45 AMBioNTech SE (NASDAQ:BNTX) Shares Sold by Vontobel Holding Ltd.marketbeat.com - April 18 at 6:14 AMFlossbach Von Storch AG Boosts Stock Position in BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 17 at 10:12 PMBioNTech (NASDAQ:BNTX) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - April 17 at 3:30 PMAssessing BioNTech: Insights From 11 Financial Analystsmarkets.businessinsider.com - April 17 at 2:29 PMBioNTech (NASDAQ:BNTX) Sees Unusually-High Trading Volumemarketbeat.com - April 16 at 12:45 PMBioNTech (NASDAQ:BNTX) Trading Up 2.7%marketbeat.com - April 15 at 5:31 PMBaillie Gifford & Co. Buys 86,343 Shares of BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 9 at 12:11 PMBioNTech SE (NASDAQ:BNTX) Shares Bought by LA Financiere DE L Echiquiermarketbeat.com - April 8 at 2:14 PMThree-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancerglobenewswire.com - April 7 at 2:00 PMDekaBank Deutsche Girozentrale Buys 127,951 Shares of BioNTech SE (NASDAQ:BNTX)marketbeat.com - April 7 at 12:17 PM Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. BNTX Media Mentions By Week BNTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.090.36▲Average Medical News Sentiment BNTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼389▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: argenx News Today Neurocrine Biosciences News Today Biogen News Today Bio-Techne News Today Qiagen News Today Repligen News Today Exelixis News Today Vaxcyte News Today Revolution Medicines News Today ImmunityBio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
